Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mark Robert Keaton"'
Publikováno v:
Genes and Diseases, Vol 4, Iss 3, Pp 159-162 (2017)
The human epidermal growth factor receptor 2 (HER2) is overexpressed in 25%-30% of breast cancer patients. Anti-HER2 therapies have changed the aggressive course of HER2+ breast cancer. In spite of the therapeutic benefits, their cardiotoxicities are
Publikováno v:
Genes & Diseases. 3(2):110-113
This manuscript provides a comprehensive review and highlights of the 2015 San Antonio Breast Cancer Symposium by the leading breast cancer specialists and investigators in the field.
Autor:
Natasha M. Savage, Eiko Kitamura, Ravindra Kolhe, Priyanka Raval, Josh Simmons, Rohini Chintalapally, Nita J. Maihle, Shou Ching Tang, Sangmi Kim, Mohamad Bassam Sonbol, Mark Robert Keaton, Chang-Sheng Chang
Publikováno v:
Journal of Clinical Oncology. 35:e23209-e23209
e23209 Background: Increasing literature suggests a protective role of aspirin in breast cancer. PI3K mutation is prevalent in 30% of estrogen receptor positive and 50% of HER2 receptor positive breast cancers. Aspirin inhibits prostaglandin-endopero
Autor:
Mark Robert Keaton, Howard A. Burris, Brooke R. Daniel, Mary Audrey Ackerman, Denise A. Yardley, Linda D. Bosserman, Emile Salloum, John D. Hainsworth, Sharon A. Goble, Dianna Shipley, William N. Harwin
Publikováno v:
Journal of Clinical Oncology. 33:1000-1000
1000 Background: Ixa is a microtubule stabilizer able to target mechanisms conferring taxane resistance including high b tubulin III expression, seen in TNBC. Here, we present preliminary results o...